About Coronavirus disease 2019 (COVID-19)

Shelby Baptist Medical Center is working closely with the Alabama Department of Public Health and the Centers for Disease Control and Prevention (CDC) to respond to any potential coronavirus cases in our area. We routinely treat infectious diseases at Shelby Baptist Medical Center. We have strong infection control policies, procedures, and systems in place to screen and treat patients. We are committed to keeping our patients, our staff, and our community safe. For more information about the coronavirus, go to the CDC website.


Effective 5/3/2021, by order of the Governor of Alabama and the State Health Officer, each patient or resident of this facility enjoys certain rights to have caregivers or visitors present, subject to reasonable restrictions and current guidance from the federal Centers for Medicare and Medicaid Services (CMS). If you have questions, you may ask to inspect the facility’s written policies concerning visitation.

Visitor Restrictions and Guidelines for Shelby Baptist Medical Center


Each patient may be allowed one (1) caregiver/visitor to help improve the patient’s safety, emotional well- being, physical care, and overall experience.

There will be no caregivers/visitors allowed for COVID-19 positive patients and/or patients with suspected COVID-19.

Compliance with the guidelines below is required, and if not followed may result in removal from the facility:

  • Must wear a mask at ALL times in the facility, regardless of vaccination status. Mask must cover both nose and mouth.
  • Must be 16 years of age or older.
  • Social distance while in the hospital.
  • Each floor is to establish a communication plan with families.
  • Must agree to practice appropriate hand hygiene.
  • Until further notice, there is no in-person visitation in the Behavioral Health Departments.
  • Depending on certain procedural areas, there may be additional restrictions.
Read more about how our parent company, Tenet Healthcare, is supporting our community through COVID-19.